Levicept Appoints Darlene Deptula-Hicks as CFO

Levicept Ltd announces the appointment of Darlene Deptula-Hicks as Chief Financial Officer. Deptula-Hicks brings extensive biotechnology and pharmaceutical industry experience, including successful capital raises and a Nasdaq listing at F-star Therapeutics. The appointment strengthens Levicept's senior team as the company advances late-stage development of LEVI-04, its first-in-class osteoarthritis treatment that demonstrated significant pain relief and potential disease modification in Phase II trials.